These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36877918)

  • 1. Integrative Scoring System for Survival Prediction in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Multicenter Study.
    Zhang B; Luo C; Zhang X; Hou J; Liu S; Gao M; Zhang L; Jin Z; Chen Q; Yu X; Zhang S
    JCO Clin Cancer Inform; 2023 Feb; 7():e2200015. PubMed ID: 36877918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter study.
    Shen H; Yin J; Niu R; Lian Y; Huang Y; Tu C; Liu D; Wang X; Lan X; Yuan X; Zhang J
    Radiother Oncol; 2022 Jun; 171():107-113. PubMed ID: 35461950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-Based Deep-Learning Model for Distant Metastasis-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Zhang L; Wu X; Liu J; Zhang B; Mo X; Chen Q; Fang J; Wang F; Li M; Chen Z; Liu S; Chen L; You J; Jin Z; Tang B; Dong D; Zhang S
    J Magn Reson Imaging; 2021 Jan; 53(1):167-178. PubMed ID: 32776391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma.
    Liao K; Tao HY; Zhan ZJ; Qiu WZ; Zheng RH
    Oncol Res Treat; 2021; 44(11):602-612. PubMed ID: 34601467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
    Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma.
    Gu B; Meng M; Xu M; Feng DD; Bi L; Kim J; Song S
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3996-4009. PubMed ID: 37596343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A contrast-enhanced CT radiomics-based model to identify candidates for deintensified chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma patients.
    Lin Y; Yang Z; Chen J; Li M; Cai Z; Wang X; Zhai T; Lin Z
    Eur Radiol; 2024 Feb; 34(2):1302-1313. PubMed ID: 37594526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.
    Pei W; Wang C; Liao H; Chen X; Wei Y; Huang X; Liang X; Bao H; Su D; Jin G
    BMC Cancer; 2022 Jul; 22(1):739. PubMed ID: 35794590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma.
    Yuan J; Wu M; Qiu L; Xu W; Fei Y; Zhu Y; Shi K; Li Y; Luo J; Ding Z; Sun X; Zhou S
    Oral Oncol; 2024 Nov; 158():106980. PubMed ID: 39151333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-identified multidimensional nodal features predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma.
    Liu Y; Zhang J; Wang J; Wu R; Huang X; Wang K; Qu Y; Chen X; Li Y; Zhang Y; Yi J
    Radiol Oncol; 2022 Dec; 56(4):479-487. PubMed ID: 36503717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
    Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
    Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
    Topkan E; Yucel Ekici N; Ozdemir Y; Besen AA; Mertsoylu H; Sezer A; Selek U
    Ear Nose Throat J; 2021 Feb; 100(2):NP69-NP76. PubMed ID: 31184210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
    Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
    PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study.
    Zhang L; Dong D; Li H; Tian J; Ouyang F; Mo X; Zhang B; Luo X; Lian Z; Pei S; Dong Y; Huang W; Liang C; Liu J; Zhang S
    EBioMedicine; 2019 Feb; 40():327-335. PubMed ID: 30642750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma.
    Peng L; Chen YP; Xu C; Tang LL; Chen L; Lin AH; Liu X; Sun Y; Ma J
    Oral Oncol; 2018 Nov; 86():258-265. PubMed ID: 30409310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features.
    Chen X; Li Y; Li X; Cao X; Xiang Y; Xia W; Li J; Gao M; Sun Y; Liu K; Qiang M; Liang C; Miao J; Cai Z; Guo X; Li C; Xie G; Lv X
    Oral Oncol; 2021 Jul; 118():105335. PubMed ID: 34023742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma.
    Qiang M; Li C; Sun Y; Sun Y; Ke L; Xie C; Zhang T; Zou Y; Qiu W; Gao M; Li Y; Li X; Zhan Z; Liu K; Chen X; Liang C; Chen Q; Mai H; Xie G; Guo X; Lv X
    J Natl Cancer Inst; 2021 May; 113(5):606-615. PubMed ID: 32970812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0.
    Zhong LZ; Fang XL; Dong D; Peng H; Fang MJ; Huang CL; He BX; Lin L; Ma J; Tang LL; Tian J
    Radiother Oncol; 2020 Oct; 151():1-9. PubMed ID: 32634460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma.
    Cao X; Wang X; Song J; Su Y; Wang L; Yin Y
    BMC Cancer; 2024 Apr; 24(1):435. PubMed ID: 38589858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.